facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2015
vol. 102
 
Share:
Share:
abstract:

Problems of false positive laboratory tests during qualification to the ”Program of severe plaque psoriasis treatment” on the basis of two cases

Dorota Jaśkiewicz-Nyckowska
,
Aneta Szczerkowska-Dobosz
,
Maria Czubek
,
Dorota Purzycka-Bohdan

Przegl Dermatol 2015, 102, 33–36
Online publish date: 2015/03/05
View full text Get citation
 
PlumX metrics:
Introduction. Qualification of patients for the therapeutic program of severe plaque psoriasis should be preceded by many tests. Abnormal test results require further evaluation and possibly implementation of treatment. False positive results lead to prolongation of the qualification process and may cause disqualification of the patient.

Objective. To draw attention to qualification to a drug program.

Case reports. A screening test for Lyme disease performed in a 45-year-old man, during qualification for biological treatment, was positive, but verification by Western blot showed a negative result. It caused significant prolongation of the qualification process. In a 26-year-old patient the QuantiFERON test gave a positive result. It was repeated in another laboratory and a negative result was established.

Conclusions. False-positive results may result in disqualification from biological treatment. Exchange of experience between doctors is essential for improving inclusion criteria of patients for biological therapy.
keywords:

psoriasis, biologic therapy, false positive reactions



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.